130 related articles for article (PubMed ID: 38682958)
1. Transfusion management and hemoglobin-based oxygen carrier treatment in a patient with anti-Rh17 antibody.
Mehr N; Fuja C; Simon C; Carll T; Alkhateb R; Wu S; Patel AA; Aldarweesh F
Transfusion; 2024 Jun; 64(6):1161-1166. PubMed ID: 38682958
[TBL] [Abstract][Full Text] [Related]
2. The Outcome of Hemolytic Disease of the Fetus and Newborn Caused by Anti-Rh17 Antibody: Analysis of Three Cases and Review of the Literature.
Dajak S; Ipavec N; Cuk M; Golubic Cepulic B; Mratinovic-Mikulandra J; Milardovic J; Stefanovic V
Transfus Med Hemother; 2020 Jun; 47(3):264-271. PubMed ID: 32595431
[TBL] [Abstract][Full Text] [Related]
3. Management of acute anemia in a Jehovah's Witness patient with acute lymphoblastic leukemia with polymerized bovine hemoglobin-based oxygen carrier: a case report and review of literature.
Donahue LL; Shapira I; Shander A; Kolitz J; Allen S; Greenburg G
Transfusion; 2010 Jul; 50(7):1561-7. PubMed ID: 20456679
[TBL] [Abstract][Full Text] [Related]
4. Exchange transfusion of least incompatible blood for severe hemolytic disease of the newborn due to anti-Rh17.
Li BJ; Jiang YJ; Yuan F; Ye HX
Transfus Med; 2010 Feb; 20(1):66-9. PubMed ID: 19725902
[TBL] [Abstract][Full Text] [Related]
5. A case study of 10 patients administered HBOC-201 in high doses over a prolonged period: outcomes during severe anemia when transfusion is not an option.
Zumberg M; Gorlin J; Griffiths EA; Schwartz G; Fletcher BS; Walsh K; Dao KH; Vansandt A; Lynn M; Shander A
Transfusion; 2020 May; 60(5):932-939. PubMed ID: 32358832
[TBL] [Abstract][Full Text] [Related]
6. Ethical Issues and Management of Fetal Hemolytic Anemia Caused by Anti-Rh17 in a Multipara with Rare -D- Phenotype.
Torreiter PP; Macher S; Matzhold EM; Resch B; Klaritsch P; Körmöczi GF; Polin H; Neuhold L; Schönbacher M; Schlenke P; Wagner T
Transfus Med Hemother; 2021 May; 48(3):183-187. PubMed ID: 34177424
[TBL] [Abstract][Full Text] [Related]
7. Fetal hemolytic disease due to anti-Rh17 alloimmunization.
Hirose M; Nakanishi K; Kaku S; Moro H; Hodohara K; Aotani H; Takebayashi K; Noda Y
Fetal Diagn Ther; 2004; 19(2):182-6. PubMed ID: 14764967
[TBL] [Abstract][Full Text] [Related]
8. Successful management of fetal hemolytic disease due to strong anti-Rh17 with plasma exchange and intrauterine transfusion in a woman with the D-- phenotype.
Mimura K; Endo M; Takahashi A; Doi Y; Sakuragi M; Kiyokawa T; Taniguchi H; Kitabatake Y; Handa M; Tomimatsu T; Tomiyama Y; Isaka Y; Kimura T
Int J Hematol; 2020 Jan; 111(1):149-154. PubMed ID: 31538326
[TBL] [Abstract][Full Text] [Related]
9. Recurrent pregnancy loss in a patient with anti-Rh17.
Moiz B; Salman M; Rasheed S; Qudus R; Millard G; Hyland CA; Flower RL; Wilson B; Turner R; Lopez GH; Liew YW
Transfus Med; 2024 Feb; 34(1):66-70. PubMed ID: 37941301
[TBL] [Abstract][Full Text] [Related]
10. Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17.
Denomme GA; Ryan G; Seaward PG; Kelly EN; Fernandes BJ
Transfusion; 2004 Sep; 44(9):1357-60. PubMed ID: 15318861
[TBL] [Abstract][Full Text] [Related]
11. Sensitization to multiple rh antigens by transfusion of random donor platelet concentrates in a -D- phenotype patient.
Yun JW; Kang ES; Ki CS; Koh KC; Kim DW
Ann Lab Med; 2012 Nov; 32(6):429-32. PubMed ID: 23130343
[TBL] [Abstract][Full Text] [Related]
12. Rare antibody-associated hemolytic transfusion reaction and transfusion-related acute lung injury: a case report.
Beck TN; Young NG; Erickson ML; Prats I
BMC Surg; 2017 Apr; 17(1):48. PubMed ID: 28441942
[TBL] [Abstract][Full Text] [Related]
13. Hemolytic disease of the fetus and newborn caused by anti-Hr
Sarihi R; Ahmadnejad M; Mohammadi S; Eshghi P; Herfat F; Jolharnejad S; Oodi A
Transfus Apher Sci; 2021 Feb; 60(1):102913. PubMed ID: 32943324
[TBL] [Abstract][Full Text] [Related]
14. Procuring rare (しい)* Japanese red blood cell units for a bleeding patient with anti-K11 requiring a life-saving procedure.
Rodriguez JV; Tormey CA
Immunohematology; 2022 Sep; 38(3):96-99. PubMed ID: 36190197
[TBL] [Abstract][Full Text] [Related]
15. Anti-N and anti-Do
Unnikrishnan A; Pelletier JPR; Bari S; Zumberg M; Shahmohamadi A; Spiess BD; Michael MJ; Harris N; Harrell D; Mandernach MW
Transfusion; 2019 Jun; 59(6):1907-1910. PubMed ID: 30768787
[TBL] [Abstract][Full Text] [Related]
16. Use of the blood substitute HBOC-201 in critically ill patients during sickle crisis: a three-case series.
Davis JM; El-Haj N; Shah NN; Schwartz G; Block M; Wall J; Tidswell M; DiNino E
Transfusion; 2018 Jan; 58(1):132-137. PubMed ID: 29076161
[TBL] [Abstract][Full Text] [Related]
17. D--phenotype due to RHD-RHCE hybrid transcript in a case of severe haemolytic disease of newborn with anti-Rh 17(Hrₒ) antibodies.
Mani A; Mishra G; Kulkarni S; Gupta D
Transfus Med; 2021 Oct; 31(5):383-386. PubMed ID: 34121248
[TBL] [Abstract][Full Text] [Related]
18. Hemoglobin-based oxygen carrier HBOC-201 provides higher and faster increase in oxygen tension in skeletal muscle of anemic dogs than do stored red blood cells.
Standl T; Freitag M; Burmeister MA; Horn EP; Wilhelm S; Am Esch JS
J Vasc Surg; 2003 Apr; 37(4):859-65. PubMed ID: 12663989
[TBL] [Abstract][Full Text] [Related]
19. [Autologous transfusion - from euphoria to reason: clinical practice based on scientific knowledge. (Part IV). Artificial oxygen carriers: cell-free hemoglobin solutions -- current status 2004].
Standl T
Anasthesiol Intensivmed Notfallmed Schmerzther; 2005 Jan; 40(1):38-45. PubMed ID: 15645386
[TBL] [Abstract][Full Text] [Related]
20. Blood Component Requirements and Erythrocyte Transfusion and Mortality Related to Hemoglobin Deficit in Phase III Trial of Hemoglobin-Based Oxygen Carrier: HBOC-201.
Jahr JS; Williams JP
Am J Ther; 2022 May-Jun 01; 29(3):e279-e286. PubMed ID: 35421008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
